Selective preservation of immune competence in human longevity: Youth-like cellular features and molecular support programs

Selective preservation of immune competence in human longevity: Youth-like cellular features and molecular support programs

Xia-Yan Wang
1,2,#
,
Fan-Qian Yin
1,#
,
Qing-Peng Kong
1,3,*
*Correspondence to: Qing-Peng Kong, State Key Laboratory of Genetic Evolution and Animal Models, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Key Laboratory of Healthy Aging Study, KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, Yunnan, China; CAS Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming 650201, Yunnan, China. E-mail: kongqp@mail.kiz.ac.cn
Ageing Cancer Res Treat. 2027;4:202632. 10.70401/acrt.2026.0044
Received: July 01, 2026Accepted: September 24, 2026Published: September 29, 2026
Tips Icon
This manuscript is made available in its unedited form to allow early access to the reported findings. Further editing will be completed before final publication. As such, the content may include errors, and standard legal disclaimers are applicable.

Abstract

Advanced age is associated with immune decline and remodeling, including loss of adaptive reserve, impaired host defense, and chronic low-grade inflammation. Yet the immune phenotype of long-lived individuals (LLIs), especially centenarians, shows that immune aging is not a uniform process. Rather than reflecting global rejuvenation, longevity-associated immunity is better understood as selective preservation of immune competence, with selected cellular features retaining youth-like characteristics under the constraints of extreme age. The most direct cellular evidence comes from innate effector functions, including preserved natural killer (NK)-cell cytotoxic surveillance and neutrophil chemotaxis, phagocytosis, and redox control. T-cell findings are more heterogeneous, including maintenance of a non-inverted CD4/CD8 ratio and partial naive CD4+ T-cell reserve, while Th17/Treg data provide more limited support for preserved regulatory-inflammatory balance. Myeloid and antigen-presenting-cell programs may further support clearance and antigen handling, although direct functional evidence remains more limited. Molecular studies point to candidate support layers rather than proven causal mechanisms, including coordinated immune-cell states and communication, survival and apoptosis-regulatory programs, ribosome-inflammation balance, autophagy-lysosomal and mitochondrial quality control, and buffering of inflammatory and senescence-associated signals. Importantly, some immune changes reported in LLIs fall outside the youth-like frame: cytotoxic and effector-memory T-cell states and repertoire remodeling, humoral shifts, and complement changes are better interpreted as adaptive remodeling whose occurrence and significance depend on lifelong immunological experience. This framework places selective preservation of immune competence at the center of LLI immune biology while distinguishing it from experience-shaped adaptive remodeling.

Keywords

Centenarians, long-lived individuals, immunosenescence, youth-like immune features, inflammaging, immune remodeling, autophagy, single-cell transcriptomics

References

  • 1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet. 2012;380(9836):37-43.
    [DOI] [PubMed]
  • 2. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Aging with multimorbidity: A systematic review of the literature. Ageing Res Rev. 2011;10(4):430-439.
    [DOI] [PubMed]
  • 3. Divo MJ, Martinez CH, Mannino DM. Ageing and the epidemiology of multimorbidity. Eur Respir J. 2014;44(4):1055-1068.
    [DOI] [PubMed] [PMC]
  • 4. Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.
    [DOI] [PubMed] [PMC]
  • 5. Engberg H, Oksuzyan A, Jeune B, Vaupel JW, Christensen K. Centenarians: A useful model for healthy aging? A 29-year follow-up of hospitalizations among 40, 000 Danes born in 1905. Aging Cell. 2009;8(3):270-276.
    [DOI] [PubMed] [PMC]
  • 6. Engberg H, Christensen K, Andersen-Ranberg K, Vaupel JW, Jeune B. Improving activities of daily living in Danish centenarians: But only in women: A comparative study of two birth cohorts born in 1895 and 1905. J Gerontol A Biol Sci Med Sci. 2008;63(11):1186-1192.
    [DOI] [PubMed] [PMC]
  • 7. Zhang Y, Murata S, Schmidt-Mende K, Ebeling M, Modig K. Disease accumulation and distribution across the lifespan in Swedish centenarians and non-centenarians: A nationwide life course comparison of longevity and health resilience. EClinicalMedicine. 2025;87:103396.
    [DOI] [PubMed] [PMC]
  • 8. Zhang Y, Murata S, Schmidt-Mende K, Ebeling M, Modig K. Do people reach 100 by surviving, delaying, or avoiding diseases? A life course comparison of centenarians and non-centenarians from the same birth cohorts. Geroscience. 2025;47(3):3539-3549.
    [DOI] [PubMed] [PMC]
  • 9. Shi Z, Zhang T, Byles J, Martin S, Avery JC, Taylor AW. Food habits, lifestyle factors and mortality among oldest old Chinese: The Chinese longitudinal healthy longevity survey (CLHLS). Nutrients. 2015;7(9):7562-7579.
    [DOI] [PubMed] [PMC]
  • 10. Franceschi C, Bonafè M, Valensin S, Olivieri F, de Luca M, Ottaviani E, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244-254.
    [DOI] [PubMed]
  • 11. Nikolich-Žugich J. The twilight of immunity: Emerging concepts in aging of the immune system. Nat Immunol. 2018;19(1):10-19.
    [DOI] [PubMed]
  • 12. Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822-1832.
    [DOI] [PubMed] [PMC]
  • 13. Fulop T, Larbi A, Dupuis G, Page AL, Frost EH, Cohen AA, et al. Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes? Front Immunol. 2018;8:1960.
    [DOI] [PubMed] [PMC]
  • 14. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243-278.
    [DOI] [PubMed]
  • 15. Oh SJ, Lee JK, Shin OS. Aging and the immune system: The impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw. 2019;19(6):e37.
    [DOI] [PubMed] [PMC]
  • 16. Zatz M, Silva MVR, de Castro MV, Naslavsky MS. The 90 plus: Longevity and COVID-19 survival. Mol Psychiatry. 2022;27(4):1936-1944.
    [DOI] [PubMed]
  • 17. Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: How age influences the host immune response to coronavirus infections? Front Physiol. 2020;11:571416.
    [DOI] [PubMed] [PMC]
  • 18. Fulop T, McElhaney J, Pawelec G, Cohen AA, Morais JA, Dupuis G, et al. Frailty, inflammation and immunosenescence. Interdiscip Top Gerontol Geriatr. 2015;41:26-40.
    [DOI] [PubMed]
  • 19. Trombetta CM, Accardi G, Aiello A, Calabrò A, Caruso C, Ligotti ME, et al. Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: A serological assessment to gain insight into the resilience of older centenarians to COVID-19. Immun Ageing. 2024;21(1):44.
    [DOI] [PubMed] [PMC]
  • 20. Foley MK, Searle SD, Toloue A, Booth R, Falkenham A, Falzarano D, et al. Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study. EClinicalMedicine. 2021;37:100975.
    [DOI] [PubMed] [PMC]
  • 21. de Castro MV, Silva MVR, Naslavsky MS, Scliar MO, Nunes K, Passos-Bueno MR, et al. The oldest unvaccinated Covid-19 survivors in South America. Immun Ageing. 2022;19(1):57.
    [DOI] [PubMed] [PMC]
  • 22. Plaza-Florido A, Carrera-Bastos P, Pérez-Prieto I, Fiuza-Luces C, Radom-Aizik S, del Pozo Cruz B, et al. The long-lived immune system of centenarians. Nat Rev Immunol. 2026;26(9):634-652.
    [DOI] [PubMed]
  • 23. Alonso-Fernández P, Puerto M, Maté I, Ribera JM, de la Fuente M. Neutrophils of centenarians show function levels similar to those of young adults. J Am Geriatr Soc. 2008;56(12):2244-2251.
    [DOI] [PubMed]
  • 24. Sansoni P, Cossarizza A, Brianti V, Fagnoni F, Snelli G, Monti D, et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 1993;82(9):2767-2773.
    [PubMed]
  • 25. Sansoni P, Vescovini R, Fagnoni F, Biasini C, Zanni F, Zanlari L, et al. The immune system in extreme longevity. Exp Gerontol. 2008;43(2):61-65.
    [DOI] [PubMed]
  • 26. Wang B, Zhang Z, Ouyang Q, Zhang M, Duan M, Hu H, et al. A comprehensive single-cell atlas of three centenarian cohorts unveils unique natural killer cell signatures and enhanced mutual interactions among peripheral immune cells. eBioMedicine. 2025;120:105922.
    [DOI] [PubMed] [PMC]
  • 27. Miyaji C, Watanabe H, Minagawa M, Toma H, Kawamura T, Nohara Y, et al. Numerical and functional characteristics of lymphocyte subsets in centenarians. J Clin Immunol. 1997;17(5):420-429.
    [DOI] [PubMed]
  • 28. Wikby A, Maxson P, Olsson J, Johansson B, Ferguson FG. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: The Swedish longitudinal OCTO-immune study. Mech Ageing Dev. 1998;102(2-3):187-198.
    [DOI] [PubMed]
  • 29. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: The Swedish longitudinal OCTO immune study. Mech Ageing Dev. 2000;121(1-3):187-201.
    [DOI] [PubMed]
  • 30. Strindhall J, Nilsson BO, Löfgren S, Ernerudh J, Pawelec G, Johansson B, et al. No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study. Exp Gerontol. 2007;42(8):753-761.
    [DOI] [PubMed]
  • 31. Ledón N, Añé-Kourí AL, Ramos MB, Lorenzo-Luaces P, Silva A, Pereira K, et al. Immunosenescence and inflammatory markers in Cuban centenarians: Implications for survival. Aging Clin Exp Res. 2023;35(11):2839-2842.
    [DOI] [PubMed]
  • 32. Nasi M, Troiano L, Lugli E, Pinti M, Ferraresi R, Monterastelli E, et al. Thymic output and functionality of the IL-7/IL-7 receptor system in centenarians: Implications for the neolymphogenesis at the limit of human life. Aging Cell. 2006;5(2):167-175.
    [DOI] [PubMed]
  • 33. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, et al. CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: Implications for T cell memory. Mech Ageing Dev. 1996;86(3):173-195.
    [DOI] [PubMed]
  • 34. Fagnoni FF, Vescovini R, Passeri G, Bologna G, Pedrazzoni M, Lavagetto G, et al. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood. 2000;95(9):2860-2868.
    [PubMed]
  • 35. Kilpatrick RD, Rickabaugh T, Hultin LE, Hultin P, Hausner MA, Detels R, et al. Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol. 2008;180(3):1499-1507.
    [DOI] [PubMed] [PMC]
  • 36. Dong C, Miao YR, Zhao R, Yang M, Guo AY, Xue ZH, et al. Single-cell transcriptomics reveals longevity immune remodeling features shared by centenarians and their offspring. Adv Sci. 2022;9(36):e2204849.
    [DOI] [PubMed] [PMC]
  • 37. Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H, et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc Natl Acad Sci U S A. 2019;116(48):24242-24251.
    [DOI] [PubMed] [PMC]
  • 38. Hashimoto K, Kojima-Ishiyama M, Inokuchi H, Tagami M, Sasaki T, Mizuguchi K, et al. CD4 CTLs in supercentenarians: Signs of adaptive expansion in healthy aging. Cell Rep. 2026;45(9):117728.
    [DOI] [PubMed]
  • 39. Carrera-Bastos P, Plaza-Florido A, Santos-Lozano A, Borba V, Rodríguez-Romo G, García-Chico C, et al. The ‘autoimmunome’ of centenarians. J Transl Autoimmun. 2025;11:100295.
    [DOI] [PubMed] [PMC]
  • 40. Miyaji C, Watanabe H, Toma H, Akisaka M, Tomiyama K, Sato Y, et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum Immunol. 2000;61(9):908-916.
    [DOI] [PubMed]
  • 41. Ligotti ME, Accardi G, Aiello A, Aprile S, Calabrò A, Caldarella R, et al. Sicilian semi- and supercentenarians: Identification of age-related T-cell immunophenotype to define longevity trait. Clin Exp Immunol. 2023;214(1):61-78.
    [DOI] [PubMed] [PMC]
  • 42. Zhu H, Chen J, Liu K, Gao L, Wu H, Ma L, et al. Human PBMC scRNA-seq-based aging clocks reveal ribosome to inflammation balance as a single-cell aging hallmark and super longevity. Sci Adv. 2023;9(26):eabq7599.
    [DOI] [PubMed] [PMC]
  • 43. Zhou L, Ge M, Zhang Y, Wu X, Leng M, Gan C, et al. Centenarians alleviate inflammaging by changing the ratio and secretory phenotypes of T helper 17 and regulatory T cells. Front Pharmacol. 2022;13:877709.
    [DOI] [PubMed] [PMC]
  • 44. Wu D, Bi X, Li P, Xu D, Qiu J, Li K, et al. Enhanced insulin-regulated phagocytic activities support extreme health span and longevity in multiple populations. Aging Cell. 2023;22(5):e13810.
    [DOI] [PubMed] [PMC]
  • 45. Karagiannis TT, Dowrey TW, Villacorta-Martin C, Montano M, Reed E, Belkina AC, et al. Multi-modal profiling of peripheral blood cells across the human lifespan reveals distinct immune cell signatures of aging and longevity. EBioMedicine. 2023;90:104514.
    [DOI] [PubMed] [PMC]
  • 46. Wang Y, Zhang Y, Gong G, Liu Q, Li L, Zhang M, et al. Single-cell analysis of human peripheral blood reveals high immune response activity in successful ageing individuals. Mech Ageing Dev. 2025;223:112011.
    [DOI] [PubMed]
  • 47. Franceschi C, Salvioli S, Garagnani P, de Eguileor M, Monti D, Capri M. Immunobiography and the heterogeneity of immune responses in the elderly: A focus on inflammaging and trained immunity. Front Immunol. 2017;8:982.
    [DOI] [PubMed] [PMC]
  • 48. Weltevrede M, Eilers R, de Melker HE, van Baarle D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review. Exp Gerontol. 2016;77:87-95.
    [DOI] [PubMed]
  • 49. Ligotti ME, Accardi G, Aiello A, Calabrò A, Caruso C, Corsale AM, et al. Sicilian semi- and supercentenarians: Age-related Tγδ cell immunophenotype contributes to longevity trait definition. Clin Exp Immunol. 2024;216(1):1-12.
    [DOI] [PubMed] [PMC]
  • 50. Zhang W, Duan Y, Li Z, Niu Y, Wang B, Feng Z, et al. Association between serum IgM and all-cause mortality risk in Chinese centenarians: A prospective cohort study. Immun Ageing. 2024;21(1):70.
    [DOI] [PubMed] [PMC]
  • 51. Fortin CF, McDonald PP, Lesur O, Fülöp T. Aging and neutrophils: There is still much to do. Rejuvenation Res. 2008;11(5):873-882.
    [DOI] [PubMed]
  • 52. Lord JM, Butcher S, Killampali V, Lascelles D, Salmon M. Neutrophil ageing and immunesenescence. Mech Ageing Dev. 2001;122(14):1521-1535.
    [DOI] [PubMed]
  • 53. Gayoso I, Sanchez-Correa B, Campos C, Alonso C, Pera A, Casado JG, et al. Immunosenescence of human natural killer cells. J Innate Immun. 2011;3(4):337-343.
    [DOI] [PubMed]
  • 54. Gumá M, Angulo A, Vilches C, Gómez-Lozano N, Malats N, López-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood. 2004;104(12):3664-3671.
    [DOI] [PubMed]
  • 55. Hazeldine J, Hampson P, Lord JM. Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell. 2012;11(5):751-759.
    [DOI] [PubMed]
  • 56. Arai Y, Martin-Ruiz CM, Takayama M, Abe Y, Takebayashi T, Koyasu S, et al. Inflammation, but not telomere length, predicts successful ageing at extreme old age: A longitudinal study of semi-supercentenarians. EBioMedicine. 2015;2(10):1549-1558.
    [DOI] [PubMed] [PMC]
  • 57. Schmitt V, Rink L, Uciechowski P. The Th17/Treg balance is disturbed during aging. Exp Gerontol. 2013;48(12):1379-1386.
    [DOI] [PubMed]
  • 58. Salminen A. Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. J Mol Med. 2021;99(11):1553-1569.
    [DOI] [PubMed] [PMC]
  • 59. Sumida TS, Cheru NT, Hafler DA. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases. Nat Rev Immunol. 2024;24(7):503-517.
    [DOI] [PubMed] [PMC]
  • 60. Elyahu Y, Hekselman I, Eizenberg-Magar I, Berner O, Strominger I, Schiller M, et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv. 2019;5(8):eaaw8330.
    [DOI] [PubMed] [PMC]
  • 61. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest. 2013;123(3):958-965.
    [DOI] [PubMed] [PMC]
  • 62. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, et al. Human innate immunosenescence: Causes and consequences for immunity in old age. Trends Immunol. 2009;30(7):325-333.
    [DOI] [PubMed] [PMC]
  • 63. Jing Y, Shaheen E, Drake RR, Chen N, Gravenstein S, Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol. 2009;70(10):777-784.
    [DOI] [PubMed] [PMC]
  • 64. Agrawal A, Agrawal S, Cao JN, Su H, Osann K, Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway. J Immunol. 2007;178(11):6912-6922.
    [DOI] [PubMed]
  • 65. Borras C, Abdelaziz KM, Gambini J, Serna E, Inglés M, de la Fuente M, et al. Human exceptional longevity: Transcriptome from centenarians is distinct from septuagenarians and reveals a role of Bcl-xL in successful aging. Aging. 2016;8(12):3185-3208.
    [DOI] [PubMed] [PMC]
  • 66. Xiao FH, Chen XQ, Yu Q, Ye Y, Liu YW, Yan D, et al. Transcriptome evidence reveals enhanced autophagy-lysosomal function in centenarians. Genome Res. 2018;28(11):1601-1610.
    [DOI] [PubMed] [PMC]
  • 67. Xiao FH, Wang HT, Zhao L, Li GH, Ma SY, Yang LQ, et al. Preserved mitochondrial ribosomal protein gene expression marks a youthful transcriptional state in Chinese nonagenarians and centenarians. Cell Rep Med. 2026;7(5):102767.
    [DOI] [PubMed] [PMC]
  • 68. Pinti M, Troiano L, Nasi M, Bellodi C, Ferraresi R, Mussi C, et al. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: How the immune system starts its second century. Circulation. 2004;110(19):3108-3114.
    [DOI] [PubMed]
  • 69. Luo OJ, Lei W, Zhu G, Ren Z, Xu Y, Xiao C, et al. Multidimensional single-cell analysis of human peripheral blood reveals characteristic features of the immune system landscape in aging and frailty. Nat Aging. 2022;2(4):348-364.
    [DOI] [PubMed]
  • 70. Phadwal K, Alegre-Abarrategui J, Watson AS, Pike L, Anbalagan S, Hammond EM, et al. A novel method for autophagy detection in primary cells: Impaired levels of macroautophagy in immunosenescent T cells. Autophagy. 2012;8(4):677-689.
    [DOI] [PubMed] [PMC]
  • 71. Macian F. Autophagy in T cell function and aging. Front Cell Dev Biol. 2019;7:213.
    [DOI] [PubMed] [PMC]
  • 72. Emanuele E, Minoretti P, Sanchis-Gomar F, Pareja-Galeano H, Yilmaz Y, Garatachea N, et al. Can enhanced autophagy be associated with human longevity? Serum levels of the autophagy biomarker beclin-1 are increased in healthy centenarians. Rejuvenation Res. 2014;17(6):518-524.
    [DOI] [PubMed]
  • 73. Montégut L, Lambertucci F, Moledo-Nodar L, Fiuza-Luces C, Rodríguez-López C, Serra-Rexach JA, et al. Acyl-CoA-binding protein as a driver of pathological aging. Proc Natl Acad Sci U S A. 2025;122(28):e2501584122.
    [DOI] [PubMed] [PMC]
  • 74. Raz Y, Guerrero-Ros I, Maier A, Slagboom PE, Atzmon G, Barzilai N, et al. Activation-induced autophagy is preserved in CD4+ T-cells in familial longevity. J Gerontol A Biol Sci Med Sci. 2017;72(9):1201-1206.
    [DOI] [PubMed] [PMC]
  • 75. Baechle JJ, Chen N, Makhijani P, Winer S, Furman D, Winer DA. Chronic inflammation and the hallmarks of aging. Mol Metab. 2023;74:101755.
    [DOI] [PubMed] [PMC]
  • 76. Liberale L, Badimon L, Montecucco F, Lüscher TF, Libby P, Camici GG. Inflammation, aging, and cardiovascular disease. J Am Coll Cardiol. 2022;79(8):837-847.
    [DOI] [PubMed] [PMC]
  • 77. Basile G, Paffumi I, D’Angelo AG, Figliomeni P, Cucinotta MD, Pace E, et al. Healthy centenarians show high levels of circulating interleukin-22 (IL-22). Arch Gerontol Geriatr. 2012;54(3):459-461.
    [DOI] [PubMed]
  • 78. Pinti M, Gibellini L, Tartaro DL, de Biasi S, Nasi M, Borella R, et al. A comprehensive analysis of cytokine network in centenarians. Int J Mol Sci. 2023;24(3):2719.
    [DOI] [PubMed] [PMC]
  • 79. Kefaloyianni E. Soluble forms of cytokine and growth factor receptors: Mechanisms of generation and modes of action in the regulation of local and systemic inflammation. FEBS Lett. 2022;596(5):589-606.
    [DOI] [PubMed] [PMC]
  • 80. Bagnara GP, Bonsi L, Strippoli P, Bonifazi F, Tonelli R, D’Addato S, et al. Hemopoiesis in healthy old people and centenarians: Well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network. J Gerontol A Biol Sci Med Sci. 2000;55(2):B61-B66.
    [DOI] [PubMed]
  • 81. Sayed N, Huang Y, Nguyen K, Krejciova-Rajaniemi Z, Grawe AP, Gao T, et al. An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging. Nat Aging. 2021;1:598-615.
    [DOI] [PubMed] [PMC]
  • 82. Accardi G, Bono F, Cammarata G, Aiello A, Herrero MT, Alessandro R, et al. miR-126-3p and miR-21-5p as hallmarks of bio-positive ageing; correlation analysis and machine learning prediction in young to ultra-centenarian Sicilian population. Cells. 2022;11(9):1505.
    [DOI] [PubMed] [PMC]
  • 83. Morsiani C, Terlecki-Zaniewicz L, Skalicky S, Bacalini MG, Collura S, Conte M, et al. Circulating miR-19a-3p and miR-19b-3p characterize the human aging process and their isomiRs associate with healthy status at extreme ages. Aging Cell. 2021;20(7):e13409.
    [DOI] [PubMed] [PMC]
  • 84. Teo YV, Capri M, Morsiani C, Pizza G, Faria AMC, Franceschi C, et al. Cell-free DNA as a biomarker of aging. Aging Cell. 2019;18(1):e12890.
    [DOI] [PubMed] [PMC]
  • 85. Tedone E, Ejun H, O’Hara R, Batten K, Ludlow AT, Lai TP, et al. Telomere length and telomerase activity in T cells are biomarkers of high-performing centenarians. Aging Cell. 2019;18(1):e12859.
    [DOI] [PubMed] [PMC]
  • 86. Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18(4):519-532.
    [DOI] [PubMed] [PMC]
  • 87. Abo Qoura L, Churov AV, Maltseva ON, Eruslanova KA, Zeng G. Senescent cells in systemic aging: SASP heterogeneity, immune escape, and endocrine modulation. Biogerontology. 2026;27(3):103.
    [DOI] [PubMed]
  • 88. Storci G, De Carolis S, Papi A, Bacalini MG, Gensous N, Marasco E, et al. Genomic stability, anti-inflammatory phenotype, and up-regulation of the RNAseH2 in cells from centenarians. Cell Death Differ. 2019;26(9):1845-1858.
    [DOI] [PubMed] [PMC]
  • 89. Sebastiani P, Federico A, Morris M, Gurinovich A, Tanaka T, Chandler KB, et al. Protein signatures of centenarians and their offspring suggest centenarians age slower than other humans. Aging Cell. 2021;20(2):e13290.
    [DOI] [PubMed] [PMC]
  • 90. Pavlidis N, Stanta G, Audisio RA. Cancer prevalence and mortality in centenarians: A systematic review. Crit Rev Oncol Hematol. 2012;83(1):145-152.
    [DOI] [PubMed]
  • 91. Harding C, Pompei F, Lee EE, Wilson R. Cancer suppression at old age. Cancer Res. 2008;68(11):4465-4478.
    [DOI] [PubMed]
  • 92. Sierra F, Kohanski R. Geroscience and the trans-NIH geroscience interest group, GSIG. Geroscience. 2017;39(1):1-5.
    [DOI] [PubMed] [PMC]
  • 93. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: Linking aging to chronic disease. Cell. 2014;159(4):709-713.
    [DOI] [PubMed] [PMC]

© The Author(s) 2027. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Publisher’s Note

Science Exploration remains a neutral stance on jurisdictional claims in published maps and institutional affiliations. The views expressed in this article are solely those of the author(s) and do not reflect the opinions of the Editors or the publisher.

Share And Cite

Science Exploration Style
Wang XY, Yin FQ, Kong QP. Selective preservation of immune competence in human longevity: Youth-like cellular features and molecular support programs. Ageing Cancer Res Treat. 2027;4:202632. https://doi.org/10.70401/acrt.2026.0044

Submit a Manuscript
Author Instructions
Cite this Article
Export Citation
Article Metrics
0
View
0
Download
Cited
Article Updates
Citation Icon Get citation